Discover 1,727 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,727
Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Pontiac MI, Livonia MI, Canton MI, Ypsilanti MI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase 3, Recruiting
A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers
for
Diabetic Foot Ulcers
Location: Southfield MI, Hamilton, Kittaning PA, Chicago IL,
Sponsor: SANUWAVE, Inc.
Sex: All
Age: 22+
Code: NCT01824407
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
FastThread Interference Screws
for
ACL Injury
Location: Bingham Farms MI
Sponsor: Arthrex, Inc.
Sex: All
Age: 18+
Code: NCT04689061
Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Detroit MI, Grand Rapids MI, Columbus OH, Toronto,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase 3, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Detroit MI, Grand Rapids MI, Hamilton, Buffalo NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase 3, Recruiting
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
for
Diffuse Large B-Cell Lymphoma
Location: Detroit MI, Towson MD, Beltsville MD, Des Moines IA,
Sponsor: AstraZeneca
Sex: All
Age: 65 - 70+
Code: NCT05952024
Phase 2, Recruiting
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Detroit MI, Ann Arbor MI, Chicago IL, Milwaukee WI,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05850234
Phase 1, Phase 2, Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: Detroit MI, Hamilton, Brampton, Toronto, Chicago IL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07291037
Phase 3, Recruiting
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
for
Sepsis, Acute Kidney Injury
Location: Detroit MI, Philadelphia PA, Winston-Salem NC,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07215702
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
for
CKD, Metabolic Acidosis
Location: Detroit MI, Pontiac MI, Chicago IL, Indianapolis IN,
Sponsor: Renibus Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07355062
Phase 3, Recruiting
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Detroit MI, Grand Rapids MI, Brampton, Toronto,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06921785
Phase 3, Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
for
Delayed Graft Function, DGF, Kidney Transplant
Location: Detroit MI, Ann Arbor MI, Toronto, Chicago IL,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06830798
Phase 3, Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Pontiac MI, Livonia MI, Canton MI, Ann Arbor MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06770582
Phase 2, Recruiting
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
for
Renal Pelvis and Ureter Urothelial Carcinoma
Location: Pontiac MI, Livonia MI, Macomb MI, Canton MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04628767
Phase 2, Phase 3, Recruiting
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
for
Advanced Lung Non-Small Cell Carcinoma,
Location: Pontiac MI, Livonia MI, Canton MI, Ypsilanti MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 70+
Code: NCT06096844
Phase 3, Recruiting
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
for
Uncontrolled Gout
Location: Troy MI, Saint Clair Shores MI, Lansing MI,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT07388498
Phase 3, Recruiting
Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis
for
Primary Knee Osteoarthritis
Location: Troy MI, New Orleans LA, Longwood FL, Miami FL